Results 271 to 280 of about 89,178 (311)
Some of the next articles are maybe not open access.

Postmenopausal Osteoporosis

Medical Clinics of North America, 1987
Osteoporosis is a major public health problem, particularly for the postmenopausal woman. With the withdrawal of estrogen at menopause, bone resorption begins to exceed formation in remodeling cycles and bone mass is inexorably lost. Clearly, preventing postmenopausal osteoporosis is the aim of management.
S J, Silverberg, R, Lindsay
  +9 more sources

Postmenopausal osteoporosis

Current Opinion in Endocrinology, Diabetes & Obesity, 2013
The aim of this study is to provide a thorough updated review of the diagnosis and treatment of postmenopausal osteoporosis.There have been several important findings in the field of postmenopausal osteoporosis over the past 1-2 years. Fewer morphometric vertebral fractures were found in women treated for 6 years with zoledronic acid compared with ...
Dima L, Diab, Nelson B, Watts
openaire   +2 more sources

Postmenopausal osteoporosis

Current Osteoporosis Reports, 2004
The postmenopausal state is the most common underlying cause for osteoporosis and most of our understanding of the condition relates to this group. Recent evidence has suggested that hormone therapy may no longer have the pre-eminent place it once held but the same studies have also confirmed its antifracture efficacy. However, an increasing variety of
openaire   +4 more sources

Postmenopausal osteoporosis management

Current Opinion in Obstetrics and Gynecology, 2000
Osteoporosis is perhaps the widest-ranging social, physical, and economic impact of estrogen deficiency. Postmenopausal bone loss is the major determinant of osteoporosis. Osteoporotic risk can be determined by measuring bone mineral density using dual X-ray absorptiometry.
M, Gambacciani, M, Ciaponi
openaire   +2 more sources

Management of postmenopausal osteoporosis

European Journal of Obstetrics & Gynecology and Reproductive Biology, 1994
More than 25% of postmenopausal women are at risk of osteoporosis. In order to avoid its consequences, it is necessary to find an appropriate prevention and/or treatment. We studied: (1) 15 postmenopausal women treated with percutaneous estradiol (50 micrograms/24 h) plus MPA (10 mg/10 days/month); (2) 15 postmenopausal women treated with synthetic ...
DI RENZO, Giancarlo   +5 more
openaire   +5 more sources

POSTMENOPAUSAL OSTEOPOROSIS

Journal of the American Medical Association, 1941
Our object in this paper is to point out the existence of postmenopausal osteoporosis and to describe its clinical features. Some metabolic data showing the effects of therapy with estrogens and other agents are incorporated in other papers.1 It will probably be well to start by explaining and defining the term "osteoporosis." Adult bone is normally ...
FULLER ALBRIGHT   +2 more
openaire   +1 more source

Postmenopausal Osteoporosis

New England Journal of Medicine, 2023
Marcella Donovan, Walker   +1 more
openaire   +2 more sources

Postmenopausal osteoporosis

Medical Journal of Australia, 1988
R L, Prince, R, Price, M, Smith
openaire   +2 more sources

Home - About - Disclaimer - Privacy